BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 26011409)

  • 1. A lethal coexistence: Pulmonary hypertension with pregnancy.
    Aksu U; Topcu S; Tanboga IH
    Int J Cardiol; 2015 Sep; 195():27-8. PubMed ID: 26011409
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of iloprost in early pregnancy in patients with pulmonary arterial hypertension.
    Elliot CA; Stewart P; Webster VJ; Mills GH; Hutchinson SP; Howarth ES; Bu'lock FA; Lawson RA; Armstrong IJ; Kiely DG
    Eur Respir J; 2005 Jul; 26(1):168-73. PubMed ID: 15994404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute resynchronization with inhaled iloprost in a pregnant woman with idiopathic pulmonary artery hypertension.
    Cotrim C; Simões O; Loureiro MJ; Cordeiro P; Miranda R; Silva C; Avillez T; Carrageta M
    Rev Port Cardiol; 2006 May; 25(5):529-33. PubMed ID: 16910160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case 5--2013: Pregnant patient with uncorrected, undiagnosed total anomalous pulmonary venous return and severe pulmonary hypertension.
    Tiouririne M; Baum VC; Battle RW; Arendt KW; Bhatt AB
    J Cardiothorac Vasc Anesth; 2013 Oct; 27(5):1041-7. PubMed ID: 24054189
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-coagulation complications in pregnancies with severe pulmonary arterial hypertension.
    Herrero T; Martin E; Poch DS; Roeder HA
    J Matern Fetal Neonatal Med; 2018 May; 31(9):1209-1213. PubMed ID: 28353362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute myocardial infarction in pregnancy.
    Bernardon M; Limone A; Businelli C; Maso GP; Piccoli M; Alberico S
    Minerva Ginecol; 2008 Dec; 60(6):551. PubMed ID: 18981981
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostacyclin therapy increases right ventricular capillarisation in a model for flow-associated pulmonary hypertension.
    van Albada ME; Berger RM; Niggebrugge M; van Veghel R; Cromme-Dijkhuis AH; Schoemaker RG
    Eur J Pharmacol; 2006 Nov; 549(1-3):107-16. PubMed ID: 16978602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iloprost as 'rescue' therapy for pulmonary hypertension of the neonate.
    De Luca D; Zecca E; Piastra M; Romagnoli C
    Paediatr Anaesth; 2007 Apr; 17(4):394-5. PubMed ID: 17359413
    [No Abstract]   [Full Text] [Related]  

  • 9. Intrathecal morphine analgesia and low-dose dopamine for oliguria in severe maternal pulmonary hypertension. A case report.
    Leduc L; Kirshon B; Diaz SF; Cotton DB
    J Reprod Med; 1990 Jul; 35(7):727-9. PubMed ID: 2376860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term echocardiographic follow-up of a patient with primary pulmonary hypertension receiving iloprost inhalations.
    Pettersen E; Morstøl TH; Vegsundvåg JA
    Eur J Echocardiogr; 2005 Jan; 6(1):67-71. PubMed ID: 15664556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical course of familial primary pulmonary hypertension in a 39-year-old female and her two children].
    Wozakowska-Kapłon B; Stepień-Wałek A; Błaszczyk A; Torbicki A
    Kardiol Pol; 2009 May; 67(5):521-5. PubMed ID: 19521938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New therapeutic agents for pulmonary vascular disease.
    Howard LS; Morrell NW
    Paediatr Respir Rev; 2005 Dec; 6(4):285-91. PubMed ID: 16298312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aerosolized iloprost combined with a phosphodiesterase inhibitor in the treatment of primary pulmonary hypertension].
    Isa R; Castro P; Martínez A
    Rev Med Chil; 2004 Mar; 132(3):353-6. PubMed ID: 15376573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bosentan improves exercise tolerance and Tei index in patients with pulmonary hypertension and prostanoid therapy.
    Seyfarth HJ; Pankau H; Hammerschmidt S; Schauer J; Wirtz H; Winkler J
    Chest; 2005 Aug; 128(2):709-13. PubMed ID: 16100158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of patients with idiopathic pulmonary arterial hypertension after listing for transplantation: impact of iloprost and bosentan treatment.
    Dandel M; Lehmkuhl HB; Mulahasanovic S; Weng Y; Kemper D; Grauhan O; Knosalla C; Hetzer R
    J Heart Lung Transplant; 2007 Sep; 26(9):898-906. PubMed ID: 17845928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable outcome of pregnancy with an elective use of epoprostenol and sildenafil in women with severe pulmonary hypertension.
    Goland S; Tsai F; Habib M; Janmohamed M; Goodwin TM; Elkayam U
    Cardiology; 2010; 115(3):205-8. PubMed ID: 20173324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of combination therapy with inhaled nitric oxide and iloprost in patients with pulmonary hypertension and right ventricular dysfunction after high-risk cardiac surgery.
    Antoniou T; Koletsis EN; Prokakis C; Rellia P; Thanopoulos A; Theodoraki K; Zarkalis D; Sfyrakis P
    J Cardiothorac Vasc Anesth; 2013 Jun; 27(3):459-66. PubMed ID: 23063102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal primary pulmonary hypertension associated with pregnancy.
    Martínez JM; Comas C; Sala X; Gratacós E; Torres PJ; Fortuny A
    Eur J Obstet Gynecol Reprod Biol; 1994 Apr; 54(2):143-7. PubMed ID: 8070600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with inhaled iloprost and bosentan in portopulmonary hypertension.
    Hoeper MM; Seyfarth HJ; Hoeffken G; Wirtz H; Spiekerkoetter E; Pletz MW; Welte T; Halank M
    Eur Respir J; 2007 Dec; 30(6):1096-102. PubMed ID: 17652314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pulmonary hypertension and pregnancy].
    Valdés G; Matthei R; Fernández MS; Schacht C; Corthorn J; Germaín AM
    Rev Med Chil; 2002 Feb; 130(2):201-8. PubMed ID: 11974533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.